Arch Biopartners Inc is a clinical-stage biotechnology company based in Toronto, Canada. It develops drug candidates that target inflammation in acute and chronic conditions, with programmes aimed at protecting the kidneys and other organs during serious illness. Its work includes treatments for conditions such as acute kidney injury and sepsis, and it advances these candidates through preclinical and clinical testing. The company works with hospital and medical research settings and partners on developing its therapeutic candidates.
The shares are listed on the TSX Venture Exchange in Canada under the code ARCH, and the price on this page is in Canadian dollars (CAD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #432 of 1501 on the TSX Venture Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Canada yet.
TrendStrong
79/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average9.3%
From 52-week high-40.0%
MomentumFair
65/100
Typical recent returns for this exchange.
See the numbers →
3-month return-1.1%
6-month return81.3%
12-month, skipping last month-14.7%
Stability (higher is calmer)Weak
39/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)92.0%
Worst drawdown, 1 year (smaller is calmer)-71.7%
LiquidityStrong
80/100
Trades actively.
See the numbers →
Avg daily value traded0.05M CAD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Canada when fundamentals data for this market is added. All Canada stocks.
52-wk range 0.390 – 1.450Daily closes, split-adjusted
Signals
50-day average0.936
200-day average0.796
Golden/death cross (60d)Golden, 44 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.067
Technical summary
Daily
Neutral
8 bullish · 1 neutral · 7 bearish
Weekly
Bearish
4 bullish · 1 neutral · 7 bearish
Monthly
Strongly bearish
1 bullish · 1 neutral · 6 bearish
Moving averages (daily)
SMA 10
0.85
Bullish
EMA 10
0.86
Bullish
SMA 20
0.85
Bullish
EMA 20
0.86
Bullish
SMA 50
0.94
Bearish
EMA 50
0.88
Bearish
SMA 100
0.86
Bullish
EMA 100
0.86
Bullish
SMA 200
0.80
Bullish
EMA 200
0.90
Bearish
Oscillators (daily)
RSI (14)
50.04
Neutral
MACD (12, 26)
-0.01
Bearish
Momentum (12)
1.16
Bullish
Stochastic %K (14)
90.00
Bearish
Williams %R (14)
-10.00
Bearish
CCI (20)
109.9
Bearish
Pivot points (classic, last session)
S3
0.84
S2
0.84
S1
0.86
Pivot
0.86
R1
0.88
R2
0.88
R3
0.90
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in CAD. Educational only, not financial advice.
